Why Kalydeco is the FDA's biggest approval of 2012

12/26/2012 | Forbes

Of the 40 new drug approvals by the FDA this year, one stands out above the rest, Matthew Herper writes. The Cystic Fibrosis Foundation played a pivotal role in the development of Vertex's cystic fibrosis treatment Kalydeco, which directly acts on a gene that can cause cystic fibrosis, and groups such as the Michael J. Fox Foundation, the Multiple Myeloma Research Foundation and Myelin Repair are playing similar roles in drug development.

View Full Article in:

Forbes

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA